165 related articles for article (PubMed ID: 20802083)
1. Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies and tumor necrosis factor alpha.
Ravnikar M; Strukelj B; Obermajer N; Lunder M; Berlec A
Appl Environ Microbiol; 2010 Oct; 76(20):6928-32. PubMed ID: 20802083
[TBL] [Abstract][Full Text] [Related]
2. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa.
Simčič S; Berlec A; Stopinšek S; Štrukelj B; Orel R
World J Microbiol Biotechnol; 2019 Feb; 35(3):45. PubMed ID: 30810891
[TBL] [Abstract][Full Text] [Related]
3. Lactic Acid Bacteria with Concomitant IL-17, IL-23 and TNFα- Binding Ability for the Treatment of Inflammatory Bowel Disease.
Kosler S; Strukelj B; Berlec A
Curr Pharm Biotechnol; 2017; 18(4):318-326. PubMed ID: 28190384
[TBL] [Abstract][Full Text] [Related]
4. Production of functionalized biopolyester granules by recombinant Lactococcus lactis.
Mifune J; Grage K; Rehm BH
Appl Environ Microbiol; 2009 Jul; 75(14):4668-75. PubMed ID: 19465535
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate carrier proteins for surface display on Lactococcus lactis by theoretical and experimental analyses of the surface proteome.
Berlec A; Zadravec P; Jevnikar Z; Štrukelj B
Appl Environ Microbiol; 2011 Feb; 77(4):1292-300. PubMed ID: 21183632
[TBL] [Abstract][Full Text] [Related]
6. Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody.
Zahirović A; Berlec A
Microb Cell Fact; 2022 Jul; 21(1):143. PubMed ID: 35842694
[TBL] [Abstract][Full Text] [Related]
7. Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation.
Plavec TV; Klemenčič K; Kuchař M; Malý P; Berlec A
Eur J Pharm Sci; 2023 Nov; 190():106568. PubMed ID: 37619953
[TBL] [Abstract][Full Text] [Related]
8. Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice.
Chiabai MJ; Almeida JF; de Azevedo MGD; Fernandes SS; Pereira VB; de Castro RJA; Jerônimo MS; Sousa IG; de Souza Vianna LM; Miyoshi A; Bocca AL; Maranhão AQ; Brigido MM
BMC Biotechnol; 2019 Jun; 19(1):38. PubMed ID: 31238939
[TBL] [Abstract][Full Text] [Related]
9. Production, secretion and purification of a correctly folded staphylococcal antigen in Lactococcus lactis.
Samazan F; Rokbi B; Seguin D; Telles F; Gautier V; Richarme G; Chevret D; Varela PF; Velours C; Poquet I
Microb Cell Fact; 2015 Jul; 14():104. PubMed ID: 26178240
[TBL] [Abstract][Full Text] [Related]
10. Functional display of a heterologous protein on the surface of Lactococcus lactis by means of the cell wall anchor of Staphylococcus aureus protein A.
Steidler L; Viaene J; Fiers W; Remaut E
Appl Environ Microbiol; 1998 Jan; 64(1):342-5. PubMed ID: 9435087
[TBL] [Abstract][Full Text] [Related]
11. Lactococcus lactis as a cell factory for delivery of therapeutic proteins.
Bahey-El-Din M; Gahan CG; Griffin BT
Curr Gene Ther; 2010 Feb; 10(1):34-45. PubMed ID: 20156189
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified Lactococcus lactis producing a green fluorescent protein-bovine lactoferrin fusion protein suppresses proinflammatory cytokine expression in lipopolysaccharide-stimulated RAW 264.7 cells.
Shigemori S; Namai F; Yamamoto Y; Nigar S; Sato T; Ogita T; Shimosato T
J Dairy Sci; 2017 Sep; 100(9):7007-7015. PubMed ID: 28690060
[TBL] [Abstract][Full Text] [Related]
13. Recombinant mouse calcitonin gene-related peptide secreted by Lactococcus lactis inhibits lipopolysaccharide-induced inflammatory response in macrophages.
Namai F; Yamamoto Y; Sato T; Ogita T; Shimosato T
Anim Sci J; 2018 Dec; 89(12):1707-1711. PubMed ID: 30294861
[TBL] [Abstract][Full Text] [Related]
14. Surface expression of Helicobacter pylori urease subunit B gene E fragment on Lactococcus lactis by means of the cell wall anchor of Staphylococcus aureus protein A.
Song D; Gu Q
Biotechnol Lett; 2009 Jul; 31(7):985-9. PubMed ID: 19267231
[TBL] [Abstract][Full Text] [Related]
15. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A.
O'Brien L; Kerrigan SW; Kaw G; Hogan M; Penadés J; Litt D; Fitzgerald DJ; Foster TJ; Cox D
Mol Microbiol; 2002 May; 44(4):1033-44. PubMed ID: 12010496
[TBL] [Abstract][Full Text] [Related]
16. p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin.
Škrlec K; Zadravec P; Hlavničková M; Kuchař M; Vaňková L; Petroková H; Křížová L; Černý J; Berlec A; Malý P
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29966384
[TBL] [Abstract][Full Text] [Related]
17. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion.
Morello E; Bermúdez-Humarán LG; Llull D; Solé V; Miraglio N; Langella P; Poquet I
J Mol Microbiol Biotechnol; 2008; 14(1-3):48-58. PubMed ID: 17957110
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous lactic acidification and coagulation by using recombinant Lactococcus lactis strain.
Raftari M; Ghafourian S; Abu Bakar F
J Appl Microbiol; 2017 Apr; 122(4):1009-1019. PubMed ID: 28028882
[TBL] [Abstract][Full Text] [Related]
19. HtrA is essential for efficient secretion of recombinant proteins by Lactococcus lactis.
Sriraman K; Jayaraman G
Appl Environ Microbiol; 2008 Dec; 74(23):7442-6. PubMed ID: 18836019
[TBL] [Abstract][Full Text] [Related]
20. Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit.
Zadravec P; Marečková L; Petroková H; Hodnik V; Perišić Nanut M; Anderluh G; Štrukelj B; Malý P; Berlec A
PLoS One; 2016; 11(9):e0162625. PubMed ID: 27606705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
